drugset / Trial / NCT02439996

Different Doses of IVIG for Kawasaki Disease

NCT02439996 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to investigate the effect of different doses of intravenous immunoglobulin (IVIG) (1g/kg once, 1g/kg twice, 2g/kg once) for Kawasaki disease (KD) in a multicentre, prospective,randomised trial.

Timeline

Start
2014-01
Primary completion
2016-03
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject intravenous immunoglobulin Protein / enzyme biologic 1 mg/kg Intravenous
Subject intravenous immunoglobulin Protein / enzyme biologic 2 mg/kg Intravenous

Indications